We evaluated the expression rate of the CSC markers, CD24 and CD44, in colorectal cancer cell lines, finding high co-expression in both cell lines as in our previous study, which reported that expression of CSC markers in colorectal cancer cultures present resistance to the fluorouracil/oxaliplatin chemotherapeutic scheme [6]. This evidence concerns the gene CD44 and colorectal cancer.